what are the Recommendations for Renin-Angiotensin System Inhibition With ACe Inhibitor or ARb or ARNI?
In patients with chronic symptomatic HFr eF NYHA class II or III who tolerate an ACe inhibitor or ARb, replacement by an ARNI is recommended to further reduce morbidity and mortality.